| |
Latest 10 SEC filings (by transaction date) for MGNX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Employee stock option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -42,500 | $4.82 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -3,165 | $18.22 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -5,351 | $17.74 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -232 | $16.38 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -147 | $15.51 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -42,500 | $15.07 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 42,500 | $4.82 |
Mar 8/24 | Mar 6/24 | Peters Jeffrey Stuart | Direct Ownership | Employee stock option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -8,750 | $10.15 |
Mar 8/24 | Mar 6/24 | Peters Jeffrey Stuart | Direct Ownership | Employee stock option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -10,875 | $11.50 |
Mar 8/24 | Mar 6/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -19,625 | $21.50 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for MGNX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Employee stock option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -42,500 | $4.82 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -3,165 | $18.22 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -5,351 | $17.74 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -232 | $16.38 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -147 | $15.51 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -42,500 | $15.07 |
Apr 8/24 | Apr 4/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 42,500 | $4.82 |
Mar 8/24 | Mar 6/24 | Peters Jeffrey Stuart | Direct Ownership | Employee stock option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -8,750 | $10.15 |
Mar 8/24 | Mar 6/24 | Peters Jeffrey Stuart | Direct Ownership | Employee stock option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -10,875 | $11.50 |
Mar 8/24 | Mar 6/24 | Peters Jeffrey Stuart | Direct Ownership | Common Stock | S - Open market or private sale | -19,625 | $21.50 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |